Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
12 papers
Recent·Most cited
H. Allard-Chamard, K. Hillier, M. L. Ramseier, A. Bertocchi, N. Kaneko, K. Premo, T. Lam, G. Yuen, M. Karpel, V. S. Mahajan, C. Tsekeri, J. Vencic, R. Crotty, A. Sharda, S. Barmettler, , S. Pillai
Congenital T cell activation in CTLA4-deficient patients impairs transitional to follicular B cell maturation and can be rescued by CTLA4 replacement therapy in vivo.
bioRxiv · Feb 8, 2024Immunology
M. Swetha, C. K. Keerthana, T. P. Rayginia, L. R. Nath, N. H. Haritha, K. Kalimuthu, S. Jannet, S. Pillai, K. B. Harikumar, S. Sundaram, N. P. Anto, D. H. Wu, R. S. Lankalapalli, R. Towner, N. Isakov, , R. J. Anto
This study compares the in vivo efficacy and safety of uttroside B and sorafenib in a murine model of hepatocellular carcinoma, finding Utt-B more potent and safer.
bioRxiv · Feb 1, 2022Cancer Biology
B. P. Boribong, T. J. LaSalle, Y. C. Bartsch, F. Ellett, M. E. Loiselle, J. P. Davis, A. L. K. Gonye, S. Hajizadeh, J. Kreuzer, S. Pillai, W. Haas, A. G. Edlow, A. Fasano, G. Alter, D. Irimia, , L. M. Yonker
The paper identifies neutrophil activation and NET formation in MIS-C linked to SARS-CoV-2 immune complexes, differing from acute pediatric COVID-19.
bioRxiv · Dec 18, 2021Immunology
K. Khanna, W. Raymond, J. Jin, A. R. Charbit, I. Gitlin, M. Tang, A. D. Werts, E. G. Barrett, J. M. Cox, S. M. Birch, R. Martinelli, H. S. Sperber, S. Franz, S. Pillai, A. M. Healy, , J. V. Fahy
Thiol drugs inhibit SARS-CoV-2 infection in vitro and reduce lung injury in vivo, supporting their potential as COVID-19 treatments.
bioRxiv · Dec 8, 2020 · PreprintMicrobiology
Y. Asano, J. Daccache, D. Jain, K. Ko, A. Kinloch, M. Veselits, D. Wolfgeher, A. Chang, M. Josephson, P. Cunningham, A. Tambur, A. Khan, S. Pillai, A. S. Chong, M. R. Clark
The paper identifies a unique B cell subset in renal allograft rejection that contributes to local inflammation through self-reactive antibodies and innate-like signaling.
bioRxiv · Sep 26, 2020 · PreprintImmunology
R. A. Ganesh, J. V. Raghavan, P. Sonpatki, D. Naik, P. Arunachalam, D. Shah, A. Lakshmikantha, S. Pillai, K. P. Chandrachari, K. Mariswamappa, S. L. D, N. Shah, S. Jhunjhunwala
The paper compares immune cell phenotypes in high-grade gliomas (grade III and IV) and finds differences in myeloid cell proportions and markers between tumor types and blood.
bioRxiv · Sep 26, 2020Immunology
V. S. Mahajan, H. Mattoo, N. Sun, V. V. Viswanadham, G. J. Yuen, H. Allard-Chamard, M. Ahmad, S. J. H. Murphy, C. Annaiah, Y. Tuncay, S. Pillai
The paper identifies distinct CpG modification states in B1 and B2 B cells at DNMT3A-maintained enhancers, showing differential methylation dynamics during development.
bioRxiv · Apr 30, 2020Immunology
N. Strauli, E. K. Fryer, O. Pham, M. Abdel-Mohsen, S. N. Facente, C. Pilcher, P. Pennings, S. Pillai, R. D. Hernandez
The paper analyzes HIV and antibody repertoire interactions in longitudinal samples, finding enriched V gene segments in HIV-associated AbR partitions but little evidence of antagonistic coevolution.
bioRxiv · Jun 28, 2019 · PreprintEvolutionary Biology
E. Demissie, V. Mahajan, F. Alsufyani, S. Kumari, G. J. Yuen, V. Viswanadham, J. Q. Tran, J. J. Moon, D. J. Irvine, S. Pillai
This study shows that DOCK2 deficiency leads to increased virtual memory CD8+ T cells by enhancing TCR sensitivity to weak agonists and reducing tonic TCR triggering.
bioRxiv · Mar 20, 2019Immunology
R. Utama, A. Bastian, N. Sadagopan, Y. Jin, E. Antoniou, Q. Gao, Y. J. Huang, S. Pillai, P. P. Lee, G. S. Atwal
The paper analyzes non-immune stromal gene expression in breast tumors across different stages and identifies gene expression patterns associated with cancer progression and clinical outcomes.
bioRxiv · Feb 4, 2019 · PreprintCancer Biology
V. Mahajan, F. Alsufyani, H. Mattoo, I. Rosenberg, S. Pillai
This study shows that CASD1 is essential for 9-O-acetylation of sialic acids on erythroid cells in vivo, and that this modification is recognized by specific virolectins and contributes to the TER-119 epitope.
bioRxiv · Nov 14, 2018Immunology
S. Pillai, J. Stone, S. Nakamura, T. Kiyoshima, J. Daccache, M. Yamauchi, H. Yamamoto, T. Saeki, M. Moriyama, M. Ohta, N. Ishiguro, G. J. Yuen, S. L. Murphy, V. Mahajan, H. Mattoo, T. Maehara
The paper identifies IL-4+ BATF+ T follicular helper cells in IgG4-related disease that correlate with IgG4 class switching in lymphoid organs.
bioRxiv · Mar 19, 2018Immunology